InspireMD rises after quarterly revenue beat

Shares of medical device maker InspireMD NSPR.O rise 10.61% to $1.98

Co posts Q4 revenue of $3.1 million, above analysts' average estimate of $2.6 million, according to data compiled by LSEG

Says quarterly revenue rose on early U.S. uptake of CGuard Prime, its neck artery implant to help prevent stroke, and higher international demand for CGuard, its earlier version

Expects FY26 revenue in the range of $13 million to $15 million vs. analysts' estimate of $14.6 million

Posts Q4 loss of 14 cents per share, while analysts expected a loss of 19 cents per share

NSPR shares down ~32% in 2025